NanoClaw before 2.1.17 contains a privilege escalation vulnerability in the handleApprovalsResponse function that fails to verify responder role authorization. Attackers with a valid questionId can approve or reject privileged actions like package installation by submitting approval response payloads without proper role validation.
The CVSS severity warrants an early asset and exposure review.
NanoClaw before 2.1.17 contains a privilege escalation vulnerability in the handleApprovalsResponse function that fails to verify responder role authorization. Attackers with a valid questionId can approve or reject privileged actions like package installation by submitting approval response payloads without proper role validation.
Confirm exposure before applying a vendor-supported change.
Confirm that nanocoai nanoclaw and an affected version are present.
Combine exploitation signals with asset exposure and business criticality.
Follow the vendor advisory or supported update path and preserve rollback options.
Recheck the version, service health, access paths, and relevant logs.
